Drug Type Small molecule drug |
Synonyms NXN 462 |
Target |
Mechanism nNOS inhibitors(Nitric-oxide synthase, brain inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H24N4S |
InChIKeyPRVOGTVRVMVUHG-KRWDZBQOSA-N |
CAS Registry1334212-67-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia, Postherpetic | Phase 2 | US | 01 Jan 2013 | |
Neuralgia, Postherpetic | Phase 2 | CA | 01 Jan 2013 |